Patent ID: 6297218
Filing Date: 2001-10-02
Classification: A61K,A61P,Y02E

Abstract:
A method for the treatment of atheosclersis or of myocardial or cerebral infarctions, which comprises administering a therapeutically effective amount of a phospholipid complex to a patient in need of such treatment, wherein the phospholipid complex is a complex resulting from the reaction of flavonoids extracted from Vitis vinifera with phospholipids selected from the group consisting of soy lecithin egg lecithin, phospholipids from bovine and porcine brains and skins, and compounds of the formula: ##STR1##in which R and R.sub.1, being identical or different, represent acyl groups from natural fatty acids and R.sub.2 represents (CH.sub.2)N.sup.+ (CH.sub.3),(CH.sub.2)NH.sub.2, or CH.sub.2 --CH(COOH)NH.sub.2, wherein the molar ratio of phospholipid to flavonoid is between 0.5 and 3.